Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0V8UV
|
|||
Former ID |
DNC011686
|
|||
Drug Name |
N-Hydroxy-N-methyl-3-naphthalen-1-yl-acrylamide
|
|||
Synonyms |
CHEMBL175134; N-Hydroxy-N-methyl-3-naphthalen-1-yl-acrylamide; BDBM50015100
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
![]() |
Download2D MOL |
||
Formula |
C14H13NO2
|
|||
Canonical SMILES |
CN(C(=O)C=CC1=CC=CC2=CC=CC=C21)O
|
|||
InChI |
1S/C14H13NO2/c1-15(17)14(16)10-9-12-7-4-6-11-5-2-3-8-13(11)12/h2-10,17H,1H3/b10-9+
|
|||
InChIKey |
AQTNKWXWVAWKHS-MDZDMXLPSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Arachidonate 5-lipoxygenase (5-LOX) | Target Info | Inhibitor | [1] |
BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
Resolvin D biosynthesis | ||||
Leukotriene biosynthesis | ||||
Lipoxin biosynthesis | ||||
Aspirin triggered resolvin D biosynthesis | ||||
Aspirin triggered resolvin E biosynthesis | ||||
KEGG Pathway | Arachidonic acid metabolism | |||
Metabolic pathways | ||||
Serotonergic synapse | ||||
Ovarian steroidogenesis | ||||
Toxoplasmosis | ||||
NetPath Pathway | IL4 Signaling Pathway | |||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
WikiPathways | Vitamin D Receptor Pathway | |||
Arachidonic acid metabolism | ||||
Eicosanoid Synthesis | ||||
Selenium Micronutrient Network |
References | Top | |||
---|---|---|---|---|
REF 1 | Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships. J Med Chem. 1990 Mar;33(3):992-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.